The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Vaccination: the cornerstone of an efficient healthcare system
Open accessAbstract
Vaccination has made an important contribution to the decreased incidence of numerous infectious diseases and associated mortality. In 2013, it was estimated that 103 million cases of childhood diseases in the United States had been prevented by the use of vaccines since 1924. These health effects translate into positive economic results, as vaccination can provide significant savings by avoiding the direct and indirect costs associated with treating the disease and possible long-term disability. A recent US study estimated that every dollar spent on childhood vaccination could save US$3 from a payer perspective and US$10 from a societal perspective. The first vaccines set a high standard from a public health 'return on investment' perspective, because they are highly cost-saving. Today, however, where only a few healthcare interventions are considered to be cost-saving, the challenge that decision-makers typically face is to identify such healthcare interventions that are deemed cost-effective, that is, provide extra benefit at a reasonable extra cost. Some of the newer vaccines provide a solution to some of today's important health issues, such as cervical cancers with human papillomavirus vaccines, or debilitating diseases with herpes zoster vaccines. These recent, more expensive vaccines have been shown to be cost-effective in several economic analyses. Overall, vaccination can still be regarded as one of the most cost-effective healthcare interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roush, S. W. (2007) · JAMA · doi:10.1001/jama.298.18.2155 · Cited by 633
The global value of vaccination
Ehreth, J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00623-0 · Cited by 408
Contagious Diseases in the United States from 1888 to the Present
van Panhuis, W. G., Grefenstette, J., Jung, S. Y., Chok, N. S., Cross, A., Eng, H., Lee, B. Y., Zadorozhny, V., Brown, S., Cummings, D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmms1215400 · Cited by 286
Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou, F., Shefer, A., Wenger, J., Messonnier, M., Wang, L. Y., Lopez, A., Moore, M., Murphy, T. V., Cortese, M., & Rodewald, L. (2014) · Pediatrics · doi:10.1542/peds.2013-0698 · Cited by 259
The value of vaccination: a global perspective
EHRETH, J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00377-3 · Cited by 189
Economic evaluation of strategies for the control and management of influenza in Europe
Scuffham, P., & West, P. A. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00154-8 · Cited by 104
Retrospective Cost‐Effectiveness Analyses for Polio Vaccination in the United States
Thompson, K. M., & Tebbens, R. J. D. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00831.x · Cited by 99
Eradication versus control: the economics of global infectious disease policies.
Barrett, S. A. (2004) · Europe PMC (PubMed Central) · Cited by 83
Ekwueme, D. U., Strebel, P. M., Hadler, S. C., Meltzer, M. I., Allen, J. W., & Livengood, J. R. (2000) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.154.8.797 · Cited by 66
A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination
Szucs, T. D., & Pfeil, A. M. (2013) · PharmacoEconomics · doi:10.1007/s40273-012-0020-7 · Cited by 59
Bärnighausen, T., Bloom, D. E., Cafiero, E. T., & O’Brien, J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03977.x · Cited by 45
Boccalini, S., Taddei, C., Ceccherini, V., Bechini, A., Levi, M., Bartolozzi, D., & Bonanni, P. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23827 · Cited by 39
Economic evaluation of human papilloma virus vaccination in the European Union: a critical review
Koleva, D., Compadri, P. D., Padula, A., & Garattini, L. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0529-3 · Cited by 30
Systematic review of economic evaluation studies: Are vaccination programs efficient in Spain?
García‐Altés, A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.029 · Cited by 29
The economics of vaccination from a global perspective: present and future
Ehreth, J. L. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.1.19 · Cited by 11
Cited by
Handbook of Religion and Health
Koenig, H. G., VanderWeele, T., & Peteet, J. R. (2024) · doi:10.1093/oso/9780190088859.001.0001 · Cited by 1,139
Barriers to vaccination in Latin America: A systematic literature review
Guzman-Holst, A., DeAntonio, R., Prado-Cohrs, D., & Juliao, P. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.10.088 · Cited by 594
Sex differences in vaccine-induced humoral immunity
Fischinger, S., Boudreau, C. M., Butler, A. L., Streeck, H., & Alter, G. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-018-0726-5 · Cited by 410
Voo, J. Y. H., Lean, Q. Y., Ming, L. C., Md. Hanafiah, N. H., Al-Worafi, Y. M., & Ibrahim, B. (2021) · Vaccines · doi:10.3390/vaccines9111348 · Cited by 380
Rapid development and deployment of high‐volume vaccines for pandemic response
Kis, Z., Kontoravdi, C., Dey, A. K., Shattock, R., & Shah, N. (2020) · Journal of Advanced Manufacturing and Processing · doi:10.1002/amp2.10060 · Cited by 105
Metadata
- Authors
- Rémy, V., Zöllner, Y., & Heckmann, U.
- Venue
- Journal of Market Access & Health Policy
- Publisher
- MDPI AG
- Published
- 2015-01
- Volume
- 3
- Issue
- 1
- Pages
- 27041
- ISSN
- 2001-6689 (ISSN-L)
- OpenAlex
- W1905091926
- Cited by
- 256
- References
- 15
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.